Patents by Inventor JUDY JOICE

JUDY JOICE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240115463
    Abstract: The present disclosure relates to sustained release drug delivery systems. In some cases, a composition comprises an active pharmaceutical agent; at least one of sucrose acetate isobutyrate and a polyorthoester; an organic solvent; and 2,6-dimethylaniline, wherein the 2,6-dimethylaniline is present at a level less than 500 ppm. In some cases, a composition comprises N-oxide of active pharmaceutical agent at a level less than 1 wt %, based on weight of the composition. In some case, a composition comprises metal present at a level less than 5 ppm. Dosage forms and methods are also provided.
    Type: Application
    Filed: August 17, 2023
    Publication date: April 11, 2024
    Inventors: ANDREW R. MIKSZTAL, JUDY JOICE, SUSAN AUTIO, MARK P. DAVIS
  • Patent number: 11771624
    Abstract: The present disclosure relates to sustained release drug delivery systems. In some cases, a composition comprises an active pharmaceutical agent; at least one of sucrose acetate isobutyrate and a polyorthoester; an organic solvent; and 2,6-dimethylaniline, wherein the 2,6-dimethylaniline is present at a level less than 500 ppm. In some cases, a composition comprises N-oxide of active pharmaceutical agent at a level less than 1 wt %, based on weight of the composition. In some case, a composition comprises metal present at a level less than 5 ppm. Dosage forms and methods are also provided.
    Type: Grant
    Filed: January 21, 2022
    Date of Patent: October 3, 2023
    Assignee: DURECT CORPORATION
    Inventors: Andrew R. Miksztal, Judy Joice, Susan Autio, Mark P. Davis
  • Publication number: 20220273633
    Abstract: The present disclosure provides for methods of producing analgesia in a subject. In some cases, methods produce analgesia in a subject undergoing arthroscopic subacromial decompression surgery. The present disclosure also relates to improved sustained release drug delivery systems. In some cases, a composition comprises an active pharmaceutical agent; at least one of sucrose acetate isobutyrate and a polyorthoester; an organic solvent; and 2,6-dimethylaniline, wherein the 2,6-dimethylaniline is present at a level less than 500 ppm. In some cases, a composition comprises bupivacaine N-oxide at a level less than 1 wt %, based on weight of the composition. In some cases, a composition comprises metal present at a level less than 5 ppm. Dosage forms and methods are also provided.
    Type: Application
    Filed: May 13, 2022
    Publication date: September 1, 2022
    Inventors: ADRIAN NEIL VERITY, STEVEN HALLADAY, VAELING MILLER, PETER LANGECKER, DMITRI LISSIN, ANDREW R. MIKSZTAL, JUDY JOICE, SUSAN AUTIO, MARK P. DAVIS
  • Publication number: 20220273518
    Abstract: The present disclosure relates to sustained release drug delivery systems. In some cases, a composition comprises an active pharmaceutical agent; at least one of sucrose acetate isobutyrate and a polyorthoester; an organic solvent; and 2,6-dimethylaniline, wherein the 2,6-dimethylaniline is present at a level less than 500 ppm. In some cases, a composition comprises N-oxide of active pharmaceutical agent at a level less than 1 wt %, based on weight of the composition. In some case, a composition comprises metal present at a level less than 5 ppm. Dosage forms and methods are also provided.
    Type: Application
    Filed: January 21, 2022
    Publication date: September 1, 2022
    Inventors: ANDREW R. MIKSZTAL, JUDY JOICE, SUSAN AUTIO, MARK P. DAVIS
  • Patent number: 11400019
    Abstract: The present disclosure relates to sustained release drug delivery systems. In some cases, a composition comprises an active pharmaceutical agent; at least one of sucrose acetate isobutyrate and a polyorthoester; an organic solvent; and 2,6-dimethylaniline, wherein the 2,6-dimethylaniline is present at a level less than 500 ppm. In some cases, a composition comprises N-oxide of active pharmaceutical agent at a level less than 1 wt %, based on weight of the composition. In some case, a composition comprises metal present at a level less than 5 ppm. Dosage forms and methods are also provided.
    Type: Grant
    Filed: October 19, 2021
    Date of Patent: August 2, 2022
    Assignee: DURECT CORPORATION
    Inventors: Andrew R. Miksztal, Judy Joice, Susan Autio, Mark P. Davis
  • Publication number: 20220133595
    Abstract: The present disclosure relates to sustained release drug delivery systems. In some cases, a composition comprises an active pharmaceutical agent; at least one of sucrose acetate isobutyrate and a polyorthoester; an organic solvent; and 2,6-dimethylaniline, wherein the 2,6-dimethylaniline is present at a level less than 500 ppm. In some cases, a composition comprises N-oxide of active pharmaceutical agent at a level less than 1 wt %, based on weight of the composition. In some case, a composition comprises metal present at a level less than 5 ppm. Dosage forms and methods are also provided.
    Type: Application
    Filed: October 19, 2021
    Publication date: May 5, 2022
    Inventors: ANDREW R. MIKSZTAL, JUDY JOICE, SUSAN AUTIO, MARK P. DAVIS